Table 2.

Selected Characteristics of Individuals with Reported Gonorrhea Diagnoses^a During Compared to Pre COVID-19 Pandemic^b, Baltimore City, Maryland

	Pre – Pandemic (N = 1660)		During Pandemic (N = 1090)		Unadjusted Odds Ratio		Odds Ratio Adjusted for Diagnosing Provider Typec		Odds Ratio Adjusted for Diagnosing Provider Type and Aged
	n	%	n	%	OR	95% CI	aOR	95% CI	aOR	95% CI
Symptomatic e	971	58.5%	617	56.6%	0.93	(0.79, 1.08)	1.02	(0.87, 1.21)	1.02	(0.86, 1.20)
Anatomic Site of Infection
Males, any urethralf	766	46.1%	339	31.1%	0.48	(0.37, 0.62)‡	0.49	(0.37, 0.64)‡	0.51	(0.39, 0.67)‡
Males, extragenital only	172	10.4%	159	14.6%	Ref		Ref		Ref
Males, unknown site	49	3.0%	150	13.8%	3.31	(2.25, 4.89)‡	2.14	(1.41, 3.26)‡	2.21	(1.45, 3.37)‡
Female, all site	673	40.5%	442	40.6%	0.71	(0.56, 0.91)†	0.58	(0.44, 0.76)‡	0.63	(0.47, 0.82)‡
Same-Day/Empiric Treatment g	901	54.3%	539	49.4%	0.82	(0.71, 0.96)†	0.97	(0.82, 1.15)	0.96	(0.81, 1.14)
Age
<18 years old	143	8.6%	75	6.9%	0.76	(0.56, 1.03)	0.64	(0.47, 0.89)†
18–24 years old	602	36.3%	382	35.0%	0.92	(0.77, 1.10)	0.86	(0.71, 1.04)
25–34 years old	566	34.1%	391	35.9%	Ref		Ref
35–44 years old	175	10.5%	155	14.2%	1.28	(1.00, 1.65)	1.25	(0.96, 1.62)
45+ years old	174	10.5%	87	8.0%	0.72	(0.54, 0.97)*	0.80	(0.60, 1.09)
Female Sex at Birth	673	40.5%	442	40.6%	1.00	(0.86, 1.17)	0.84	(0.71, 0.99)*	0.88	(0.74, 1.04)
Race/Ethnicity
Non-Hispanic Black	1357	81.7%	876	80.4%	1.01	(0.79, 1.28)	1.13	(0.88, 1.45)	1.19	(0.93, 1.54)
Hispanic or Other Raceh	197	11.9%	126	11.6%	Ref		Ref		Ref
Unknown	106	6.4%	88	8.1%	1.30	(0.91, 1.86)	1.03	(0.71, 1.50)	1.13	(0.77, 1.64)
Diagnosing Provider Type
Sexual Health Clinic	385	23.2%	96	8.8%	Ref
Emergency Department / Urgent Care Center	198	11.9%	254	23.3%	5.14	(3.85, 6.88)‡
Hospital	473	28.5%	196	18.0%	1.66	(1.26, 2.20)‡
FQHCi	201	12.1%	185	17.0%	3.69	(2.74, 4.98)‡
Private Healthcare Provider	260	15.7%	199	18.3%	3.07	(2.30, 4.10)‡
Otherj	143	8.6%	160	14.7%	4.49	(3.27, 6.16)‡
Living with HIV k	175	10.5%	149	13.7%	1.34	(1.06, 1.70)*	1.43	(1.12, 1.83)†	1.33	(1.04, 1.72)*
Gonorrhea Diagnosis, past 12m	271	16.3%	212	19.4%	1.24	(1.01, 1.51)*	1.25	(1.02, 1.53)*	1.25	(1.02, 1.54)*
Insurance Status
Insured	1008	60.7%	850	78.0%	2.27	(1.74, 2.96)‡	1.85	(1.40, 2.45)‡	1.88	(1.42, 2.48)‡
Uninsured	226	13.6%	84	7.7%	Ref		Ref		Ref
Unknown	426	25.7%	156	14.3%	0.99	(0.72, 1.34)‡	1.01	(0.73, 1.39)	1.02	(0.74, 1.40)

^aAmong randomly sampled cases with a completed SSuN provider or patient survey.

^bDuring pandemic: March 1, 2020 – September 30, 2021; Pre-pandemic: March 1, 2018 – September 30, 2019.

^cValues shown are odds ratios for each characteristic adjusted for diagnosing provider type.

^dValues shown are odds ratios for each characteristic adjusted for diagnosing provider type and age.

^eCases with provider documented urethritis, proctitis, epididymitis, PID, discharge, or other STI-related clinical findings or who self-reported: discharge, dysuria, or other symptoms/pains believed to be caused by an STI.

^fCases with reported positive laboratory tests from urine/urethral specimens.

^gCases with documentation of receipt of CDC-recommended antimicrobial regimens for gonorrhea treatment or other microbial commonly used to treat symptoms consistent with gonorrhea on or before the date a specimen collected for laboratory testing.

^hOther Race includes White, Asian, American Indian/Alaska Native, Hawaiian/Pacific Islander, Multi-race or Other

ⁱFederally Qualified Health Center

^jIncludes outreach, schools, correctional facilities, laboratories, and reproductive health facilities.

^kDocumented HIV diagnosis reported to Maryland electronic HIV/AIDS reporting system on or before the gonorrhea diagnosis date.

^*p < 0.05

^†p < 0.01

^‡p < 0.001